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http://www.biomedcentral.com/1471-2474/15/236RESEARCH ARTICLE Open AccessIntramuscular fat in ambulant young adults with
bilateral spastic cerebral palsy
Jonathan J Noble1,3*, Geoffrey D Charles-Edwards2, Stephen F Keevil2, Andrew P Lewis1,3, Martin Gough3
and Adam P Shortland3Abstract
Background: It is known that individuals with bilateral spastic cerebral palsy (BSCP) have small and weak muscles.
However, no studies to date have investigated intramuscular fat infiltration in this group. The objective of this study
is to determine whether adults with BSCP have greater adiposity in and around their skeletal muscles than their
typically developing (TD) peers as this may have significant functional and cardio-metabolic implications for this
patient group.
Methods: 10 young adults with BSCP (7 male, mean age 22.5 years, Gross Motor Function Classification System
(GMFCS) levels I-III), and 10 TD young adults (6 male, mean age 22.8 years) took part in this study. 11 cm sections
of the left leg of all subjects were imaged using multi-echo gradient echo chemical shift imaging (mDixon).
Percentage intermuscular fat (IMAT), intramuscular fat (IntraMF) and a subcutaneous fat to muscle volume ratio
(SF/M) were calculated.
Results: IntraMF was higher with BSCP for all muscles (p = 0.001-0.013) and was significantly different between
GMFCS levels (p < 0.001), with GMFCS level III having the highest IntraMF content. IMAT was also higher with
BSCP p < 0.001). No significant difference was observed in SF/M between groups.
Conclusion: Young adults with BSCP have increased intermuscular and intramuscular fat compared to their TD
peers. The relationship between these findings and potential cardio-metabolic and functional sequelae are yet
to be investigated.
Keywords: Cerebral palsy, Intramuscular fat, Magnetic resonance imaging, Dixon imagingBackground
The mechanical potential of muscle depends on gross
morphology (cross sectional area, fibre length [1]), muscle
fibre type, and muscle composition (fraction of intra-
muscular fat and connective tissue). Anatomical mag-
netic resonance imaging (MRI) and ultrasound imaging
have demonstrated that the skeletal muscles of the
lower limbs of individuals with bilateral spastic cerebral
palsy (BSCP) are reduced in size by up to 50% compared
to the muscles of their typically developing (TD) peers
[2-4]. However, studies of microstructure and composition* Correspondence: jonathan.noble@gstt.nhs.uk
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unless otherwise stated.have been limited to a small number of biopsy studies
[5,6]. In the lower limb, these have demonstrated increases
in the connective tissue fraction, reduced muscle fibre
diameter, and altered muscle fascicle stiffness [5,6].
Decreased physical activity is associated with increased
intermuscular fat [7-10]. Due to the typically sedentary
behaviour observed in this group [11,12], one aspect of
muscle composition that may be altered in BSCP is the
level of intra- and intermuscular fat. Fatty infiltration
into muscle results in a reduced proportion of contract-
ile tissue per unit muscle volume. Intramuscular fat also
may secrete inflammatory cytokines that can reduce the
myofibrillar force even in the absence of muscle atrophy
[13]. If present in this group, raised intramuscular fat
may have important consequences for physical perform-
ance, and implications for exercise regimes employed in
their physical management [14].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Previous left leg interventions in the group of
adults with BSCP
BSCP subject Intervention
1 None
2 Gastrocnemius lengthening
3 Gastrocnemius lengthening
4 None
5 Gastrocnemius lengthening
6 Gastrocnemius lengthening
7 Gastrocnemius lengthening
8 None
9 Gastrocnemius and Achilles tendon lengthening
10 None
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have been shown to be associated with cardiovascular
risk [15,16]. Adults with cerebral palsy may have a 2–3
times greater risk of dying from ischemic heart disease
than their typically developing peers [17]. However, there
are few studies in the literature that have attempted to
document body or muscle composition in this group.
Since individuals with cerebral palsy have reduced muscle
mass, even those with body mass index (BMI) in the nor-
mal range may have relatively increased levels of adipose
tissue. Previous studies in children with cerebral palsy
have suggested raised levels of fat [18,19]. In an MRI study
of the lower limbs in children with quadriplegic cerebral
palsy (Gross Motor Function Classification System
(GMFCS) levels III-V), Johnson et al. [18] found increased
levels of intermuscular and subcutaneous fat [18]. To date,
there have been no studies of intramuscular fat in adults
or children with BSCP even though this non-invasively
quantified parameter appears to be one of those most
associated with cardio-metabolic disease [20].
T1-weighted image segmentation is primarily used to
quantify IMAT, with IMAT defined as the MRI-visible
fat within the muscles (intramuscular fat) and between the
muscles beneath the fascia (intermuscular fat). Although
this method is effective for assessing intermuscular and
subcutaneous fat volumes, it is not an accurate method
for measuring fat distribution within individual muscles.
Chemical shift magnetic resonance imaging-based water/
fat separation techniques based on that first proposed
by Dixon [21] have been developed which utilise the
chemical shift difference between fat and water to
enable reconstruction of separate water and fat images.
These techniques utilise the predictable difference in
phase evolution between water and fat signals due to
their chemical shift difference to enable the calculation
of separate water and fat images, permitting the calcu-
lation of the fat fraction. The fat fraction is the signal
intensity attributable to fat, normalised by the total
signal from all mobile proton species. These techniques
have been widely used in studies quantifying the degree of
liver fat in hepatic steatosis (for review see Reeder [22]):
although, to date, Dixon imaging has only been used in a
small number of clinical intramuscular fat quantification
studies [16,23,24].
The aim of this study is to investigate the intermus-
cular fat (IMAT), subcutaneous fat (SF) and intramus-
cular fat (IntraMF) content in five major muscles
of the leg (medial and lateral gastrocnemius, soleus,
tibialis posterior and tibialis anterior) in 10 subjects
with BSCP and 10 TD subjects using multi-echo
gradient echo chemical shift imaging (mDixon). We
hypothesised that the subjects with BSCP would
exhibit increased fat content compared to their TD
peers.Methods
Ethical approval for this study was granted by Hampstead
Research Ethics Committee London (09/H0720/120). All
subjects gave informed consent before they participated.
Subjects
Individuals aged 16 – 30 years, with a diagnosis of BSCP,
Gross Motor Function Classification System (GMFCS)
levels I-III, who met the safety requirements of MRI
were included in this study. Patients who had undergone
surgery, serial casting or botulinum toxin injections to
the lower limbs within the previous year were excluded
from the study. This was a convenience sample of
individuals attending our hospital department, with
consecutive patients that met the inclusion criteria in-
vited to participate in the study.
10 adults with a diagnosis of BSCP (7 male, 3 female,
mean age 22.5 years, range 18–27, GMFCS levels I-III
from clinics in our university hospital and a convenience
sample of 10 TD young adults (6 male, 4 female, mean
age 22.8 years, range 18–27) recruited from individuals
known to the research team participated in this study.
The BSCP subjects had undergone a range of previous
interventions (see Table 1) but none had undergone
surgery, serial casting or botulinum toxin injections to
the lower limbs within the previous year. All TD sub-
jects had no prior significant musculoskeletal trauma
or disorders.
Data collection
MR data were acquired on a 3.0 T Achieva system (Philips
Healthcare, Best, The Netherlands) running software
version 2.6.3, using an 8-channel receive-only phased
array knee coil. One subject had a 30° knee fixed flexion
deformity; instead a 32-channel cardiac coil was used.
An 11 cm section of the left leg was scanned, centred at
the largest circumference of the calf with the subject
prone. Four point gradient echo mDixon images were
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2.0 mm in-plane resolution, 4.0 mm slice thickness,
echo-time shift = 1.0 ms. Utilising the known chemical
shift between water and fat signal constituents, separate
water and fat images were calculated within the scanner
software. Subject height and body mass were measured
in standing before the MRI scan using a stadiometer and
calibrated weighing scales. Patients at our centre are
routinely classified according to GMFCS level in their
medical record by their consulting physician or surgeon.
Data processing
Regions of interest (ROIs) were manually drawn around
the SF, muscle compartment (Figure 1B), and five indi-
vidual muscles; the soleus, medial gastrocnemius, lateral
gastrocnemius, tibialis anterior, and tibialis posterior
(Figure 1C), on the mDixon water images using Osirix
version 3.7.1 [25]. SF volume was normalised to muscle
volume (Equation 1), creating a SF to muscle volume ra-
tio (SF/M). The ROIs around the entire musculature and
individual muscles were eroded with a structuring elem-
ent size of 2 pixels (4.0 mm) to remove any potential
edge effects with surrounding subcutaneous fat (or inter-
muscular fat for IntraMF quantification). IMAT and
IntraMF were calculated using a ratio of the water and
fat signal intensities within the eroded ROIs (Equation 2).
The reproducibility of the Dixon technique employed
was measured using 5 acquisitions of one TD subject
imaged over 3 visits, with the scan repeated twice during
2 of these visits. Reproducibility was defined as the aver-
age standard deviation of the measured percentage fat,
i.e. the standard deviation averaged across all muscles
investigated.
SF=M ¼ SF Volume
Muscle Volume
ð1Þ
% Fat ¼ 100 IFat
IFat þ IWater
 
ð2Þ
Where I = Signal intensity.Figure 1 Image segmentation: (A) Example mDixon water image; (B)
compartment for IMAT segmentation; and (C) the 5 muscles analysed
(SOL), medial gastrocnemius (MG) and lateral gastrocnemius (LG) forData analysis
Following application of the Kolmogorov-Smirnov test
for normality and Levene’s test for equality of variance,
independent samples t-tests were performed to investi-
gate physical characteristic differences between the two
subject groups for all measured parameters. Two-way
ANOVA was performed on IntraMF with GMFCS level
and muscle identity as fixed factors with a Tukey post-
hoc test. Non-parametric independent samples median
tests compared SF/M and IMAT between groups. The
Kruskal-Wallis Test was used to investigate differences in
SF/M and IMAT with GMFCS level. Pearson’s correlations
were used to investigate relationships between measured
parameters. All statistical tests were performed using SPSS
(Version 20.0; IBM SPSS) with significance set to p ≤ 0.05.
Results
Physical characteristics of subjects in the BSCP and TD
groups are summarised in Table 2. There were no group
differences in age, body mass, height, or BMI (p > 0.05).
The GMFCS level of the BSCP subjects are also pre-
sented in Table 2. The average standard deviation repre-
senting reproducibility of intramuscular fat averaged
across all muscles was 0.33%.
Figure 2 shows a histogram of group-averaged per-
centage IntraMF and IMAT. The BSCP group had a sig-
nificantly higher average percentage IMAT (p < 0.001)
and IntraMF compared to the TD group for all muscles
investigated (p < 0.001), with the soleus having the lar-
gest percentage fat difference (12.9% greater in BSCP
group). In the BSCP group, IntraMF was significantly
correlated between all muscles measured (r = 0.697 to
0.947, p < 0.001 to p = 0.025) except for the soleus, which
did not correlate with any other muscle (r = 0.437 to
0.587, p = 0.074 to 0.206). Figure 3 shows a histogram of
group-averaged SF/M ratio. The mean SF/M ratio was
1.9 times greater in the BSCP group compared to the
TD group; however, this difference was not statistically
significant (p = 0.179). Example images for a case and
age-matched control are given in Figure 4.manually drawn region of interest (white) for the muscle
drawn around tibialis anterior (TA), tibialis posterior (TP), soleus
IntraMF segmentation.
Table 2 Physical characteristics (mean ± standard
deviation) of BSCP and TD groups and number of BSCP
subjects in each GMFCS levels (I-III)
BSCP group TD group
Number of subjects 10 10
Age (years) 22.5 ± 2.9 22.8 ± 3.0
Sex (m,f) 7, 3 6, 4
Body mass (kg) 64.0 ± 11.5 71.2 ± 11.8
Height (m) 1.69 ± 0.08 1.76 ± 0.12
BMI (kg/m2) 22.4 ± 3.6 22.9 ± 1.7
GMFCS level I 2 N/A
GMFCS level II 5 N/A
GMFCS level III 3 N/A
Figure 3 Subcutaneous fat to muscle volume ratio in the BSCP
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nificant differences in IntraMF levels by GMFCS level
(p < 0.001), with GMFCS level III significantly higher com-
pared to GMFCS levels I and II (p < 0.001 and p = 0.001
respectively). No significant difference was observed in
IMAT or SF/M with GMFCS level (p = 0.131). In the
TD group, SF/M was correlated with IMAT (r = 0.81,
p = 0.005) but not with IntraMF (r = 0.182, p = 0.206),
and no correlation was observed between IMAT and
IntraMF (r = 0.251, p = 0.079). In the BSCP group, no
correlations were observed between SF/M and IMAT
(r = 0.392, p = 0.262) or IntraMF (r = 0.134, p = 0.353);
IMAT and IntraMF were significantly correlated (r = 0.529,
p < 0.001).Figure 2 Percentage IntraMF and IMAT in the medial
gastrocnemius (MG), lateral gastrocnemius (LG), soleus (SOL),
tibialis anterior (TA), tibialis posterior (TP) and in the BSCP
group (white) and TD group (grey). IMAT and IntraMF in all
muscles were significantly different between groups (p < 0.05).
Error bars represent the standard error of each group.
group (white) and TD group (grey). Error bars represent the
standard error of each group.Discussion
We conducted MRI measurements of IMAT, SF/M ratio,
and IntraMF on 10 young adults with BSCP and 10 of
their TD peers. This is the first study to show that
ambulant adults with BSCP have raised levels of IntraMF,
ranging from 2.3 to 34.4%. Percentage IntraMF was also
found to be significantly different between GMFCS levels,
with those at GMFCS III having greater fatty infiltration.
These differences in IntraMF by GMFCS level suggest
IntraMF maybe related to the degree of mobility impair-
ment. This may be due to decreased physical activity with
increasing mobility impairments.
The 1.9 fold greater SF/M ratio in the BSCP group is
comparable to the results of Johnson et al. [18], who
reported 2 fold greater SF/M ratio in the mid thigh of
children with quadriplegic cerebral palsy GMFCS levels
III-V [18]. This is surprising due to the higher functional
ability of the subjects in this study (GMFCS levels I-III).
IMAT values cannot be compared between these studies
due to the separation by Johnson et al. of IMAT into
Figure 4 Example water (A and C) and fat (B and D) for one subject with BSCP (A and B), and an age matched TD subject (C and D).
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and analysis techniques employed.
Clinical implications
Children and young adults with cerebral palsy have been
shown to have reduced muscle volumes in their lower
limbs [2-4,26-30] and increased IMAT [18]. This study
demonstrates that these muscles also have greater levels
of intramuscular fat that is independent of subcutaneous
fat levels. This combination of morphological and com-
positional changes may have implications both for the
mechanical performance of these skeletal muscles and
also for the predisposition of the adult with BSCP to
cardio-metabolic disease [20].
Muscle weakness is a prevalent feature of individuals
with cerebral palsy [26,31,32]. Muscle weakness, in this
group, is in part caused by an inability to fully activate
available muscular resources [33], increased co-activation
[34] and by reduced muscle volume [2-4,26-30]. For a
given muscle volume, a higher intramuscular fat content
will correspond to reduced contractile tissue content,
resulting in a weaker muscle than predicted from muscle
mass alone. Furthermore, inflammatory cytokines pro-
duced by intramuscular fat may interfere with the action
of myofibrillar proteins reducing specific force produc-
tion [13]. These secondary pathologies may contributeto a deficit in the “functional reserve” of adults with
BSCP, and may expose these individuals to a heightened
risk of immobility with increasing age [30].
Greater intramuscular fat content in BSCP may expose
these individuals to a greater risk of developing cardio-
metabolic disease [20]. There is a strong relationship
between intramuscular fat content, insulin resistance
and type-II diabetes [15,35,36]. Within skeletal muscle, fat
is stored in two separate compartments: Intramyocellular
lipid (IMCL) and extramyocellular lipid (EMCL). EMCL is
found within adipose cells adjacent to the muscle fibres,
and IMCL is located along with enzymes involved in fatty
acid esterification, hydrolysis, and transport into the mito-
chondria [37]. Enhanced storage of IMCL occurs due to
the combined effects of high concentration of serum insu-
lin and free fatty acids [38]. In particular, greater IMCL in
the soleus correlates with glucose-insulin-lipid metabolism
and insulin sensitivity [39-42], with soleus IMCL content
being the only differentiating feature in a study of lean
insulin-resistant subjects and their TD peers matched for
BMI, body fat distribution, percentage body fat and phys-
ical fitness [42]. However, IntraMF quantification using
Dixon imaging techniques measure IMCL and EMCL as a
composite. IMCL has been shown to be unrelated to mea-
sures of adiposity [39,43]. In this study IntraMF did not
correlate with SF/M. This suggests that the raised IntraMF
Figure 5 Percentage intramuscular fat in the medial
gastrocnemius (MG), lateral gastrocnemius (LG) and soleus
(SOL) for the TD group (grey), the no intervention BSCP
subjects (white) and the gastrocnemius recession BSCP
subjects (striped).
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However, although the mDixon scans showed raised
IntraMF with BSCP, whether this is due to raised IMCL,
EMCL, or both is not yet known. Therefore, further inves-
tigations are required using magnetic resonance spec-
troscopy to determine the contributions of IMCL and
EMCL to the raised IntraMF observed in this study.
Greater intramuscular fat may also be a marker of im-
paired mitochondrial content and/or function [44]. The
increased intramuscular fat content observed in this
study, particularly in the soleus, indicates that patients
with cerebral palsy may have a greater risk of develop-
ing obesity related diseases, particularly type-II diabetes.
Since IntraMF was observed to be greater with increas-
ing GMFCS level, this risk of obesity-related disease
may increase with decreasing functional ability. How-
ever, intramuscular fat is only one factor associated with
the risk of developing obesity related diseases. Future
studies of activity levels, fat levels, and glucose toler-
ance, are required to investigate the risk developing
cardio-metabolic diseases in this patient group.
Greater intramuscular fat can be caused by a chronic
mismatch between energy intake and expenditure [26,45].
Such a mismatch would also result in greater subcutane-
ous fat levels. In this study, however, despite SF/M being
greater in the BSCP group, this was not statistically
significant. This suggests that other factors as well as
any potential energy mismatch are adversely affecting
the intramuscular fat content in BSCP.
IntraMF has been correlated with deficits in central
muscle activation [46], increased risk of future mobility
loss [47,48], and insulin resistance [49] in the elderly
population. Preliminary studies have also shown that
particular exercise regimes in older adults may prevent
and decrease intramuscular fat [10]. Since skeletal
muscle in cerebral palsy has similarities with muscles
in the elderly, including reduced muscle volume [50],
increased stiffness [51] and reduced voluntary muscle
activation [33], these exercise studies could have im-
portant implications for the physical management of
this group as suggested by Peterson et al. [14].
Limitations
The number of subjects recruited may limit the scope
and power of this study. However, the differences in
intramuscular fat between the TD and BSCP groups
were large and statistically significant. The group differ-
ences were also much larger than the reproducibility of
the mDixon technique used in this study, defined as the
average standard deviation of measured percentage fat
across all muscles (0.33%).
Despite having good accuracy and reproducibility, fat-
fractions measured using multi-echo techniques are not
standardised and platform-independent. The precisionof the quantified fat fraction depends on five confound-
ing factors; T1 bias, T2* decay, spectral complexity of
fat, noise bias, and eddy currents [22]. The T1 bias and
the assumption that fat has a single frequency peak,
results in an inadvertent misidentification of some signal
from fat as arising from water, and hence to quantifica-
tion errors [52]. The T1 bias is due to the T1 weighting
of the mDixon sequence, in order to reduce scan time.
When there is partial-volume mixing of fat and muscle
tissue within pixels, signal from fat, which has a shorter T1
than water, is overestimated. Therefore, despite being suit-
able for comparisons within single site studies, comparison
of absolute values of intramuscular fat quantified in this
study across sites where different techniques and sequence
designs have been employed will be more difficult.
Six of the ten BSCP subjects had undertaken gastro-
cnemius recessions to the left leg; with one of these six
subjects also having had Achilles tendon lengthening. Since
muscle injury can lead to fatty degradation of muscle tissue
[53-56], it is possible that the histories of surgical interven-
tion received by the individuals with BSCP in this study
may have influenced the development of particular
muscles. A histogram comparing the percentage intra-
muscular fat between the TD group, BSCP subjects with
no intervention, and BSCP subjects who have previously
received gastrocnemius lengthening is given in Figure 5.
Percentage intramuscular fat was significantly dependent
on intervention and muscle (p = 0.048 and p = 0.009
respectively). Despite not being operated on directly, the
soleus had significantly higher intramuscular fat content
compared to MG and LG (p = 0.006 and p = 0.007 respect-
ively). This data suggests that gastrocnemius lengthening
may result in damage to the soleus causing fatty accumu-
lation. Longitudinal studies are required to determine
whether surgery results in greater accumulation of intra-
muscular fat, or whether those with heightened levels of
intramuscular fat are more likely to have surgery.
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matched: however, the physical characteristic differ-
ences between the two groups were minimal with no
significant difference in age, body mass, height, or BMI
observed between the groups. It is possible that the
large differences in fat levels in BSCP are due to large
differences in life style, including activity levels and diet.
Alternatively, the greater fat levels observed in this
study may be due to an inherent predisposition with
BSCP. To assess the contribution of the factors, further
research is required to identify the cause of the in-
creased intramuscular fat in BSCP.
Conclusion
Greater intramuscular fat and IMAT is found in BSCP
compared to their TD peers; with the amount of intra-
muscular fat related to GMFCS level. Despite normal
BMIs, the patients in this group may have an increased
risk of developing obesity-related diseases, with risk in-
creasing with decreasing functional ability. Furthermore,
the increasing intramuscular fat content may help to ex-
plain deficits in muscle performance in this group.
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